Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures
Autor: | Candice Julie Clarke, K. Sarun, Kenneth Lee, Marissa Williams, Casey M. Wright, Ngan Ching Cheng, Yuen Yee Cheng, Ken Takahashi |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
ddPCR CD15 Catalysis Inorganic Chemistry lcsh:Chemistry 03 medical and health sciences 0302 clinical medicine FISH CDKN2A medicine Copy-number variation Mesothelioma genomic deletion Physical and Theoretical Chemistry Molecular Biology lcsh:QH301-705.5 Spectroscopy BAP1 medicine.diagnostic_test business.industry Organic Chemistry copy number variation Cancer General Medicine medicine.disease Computer Science Applications 030104 developmental biology lcsh:Biology (General) lcsh:QD1-999 030220 oncology & carcinogenesis mesothelioma Cancer research Biomarker (medicine) biomarker business Fluorescence in situ hybridization |
Zdroj: | International Journal of Molecular Sciences, Vol 19, Iss 10, p 3056 (2018) |
ISSN: | 1422-0067 |
Popis: | Malignant pleural mesothelioma (MPM) is a deadly cancer that is caused by asbestos exposure and that has limited treatment options. The current standard of MPM diagnosis requires the testing of multiple immunohistochemical (IHC) markers on formalin-fixed paraffin-embedded tissue to differentiate MPM from other lung malignancies. To date, no single biomarker exists for definitive diagnosis of MPM due to the lack of specificity and sensitivity; therefore, there is ongoing research and development in order to identify alternative biomarkers for this purpose. In this study, we utilized primary MPM cell lines and tested the expression of clinically used biomarker panels, including CK8/18, Calretinin, CK 5/6, CD141, HBME-1, WT-1, D2-40, EMA, CEA, TAG72, BG8, CD15, TTF-1, BAP1, and Ber-Ep4. The genomic alteration of CDNK2A and BAP1 is common in MPM and has potential diagnostic value. Changes in CDKN2A and BAP1 genomic expression were confirmed in MPM samples in the current study using Fluorescence In situ Hybridization (FISH) analysis or copy number variation (CNV) analysis with digital droplet PCR (ddPCR). To determine whether MPM tissue and cell lines were comparable in terms of molecular alterations, IHC marker expression was analyzed in both sample types. The percentage of MPM biomarker levels showed variation between original tissue and matched cells established in culture. Genomic deletions of BAP1 and CDKN2A, however, showed consistent levels between the two. The data from this study suggest that genomic deletion analysis may provide more accurate biomarker options for MPM diagnosis. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |